BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7663513)

  • 1. A teratologic suppressor role for p53 in benzo[a]pyrene-treated transgenic p53-deficient mice.
    Nicol CJ; Harrison ML; Laposa RR; Gimelshtein IL; Wells PG
    Nat Genet; 1995 Jun; 10(2):181-7. PubMed ID: 7663513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of the route of administration for genetic differences in benzo[a]pyrene-induced in utero toxicity and teratogenicity.
    Legraverend C; Guenthner TM; Nebert DW
    Teratology; 1984 Feb; 29(1):35-47. PubMed ID: 6322374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative damage in chemical teratogenesis.
    Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
    Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
    van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
    Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea embryotoxicity is enhanced in P53-deficient mice.
    El Husseini N; Hales BF
    Reprod Toxicol; 2018 Oct; 81():28-33. PubMed ID: 29940331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential DNA damage in the p53 gene by benzo[a]pyrene metabolites in cytochrome P4501A1-expressing xeroderma pigmentosum group A cells.
    Quan T; States JC
    Mol Carcinog; 1996 May; 16(1):32-43. PubMed ID: 8634092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deregulation of cancer-related pathways in primary hepatocytes derived from DNA repair-deficient Xpa-/-p53+/- mice upon exposure to benzo[a]pyrene.
    van Kesteren PC; Zwart PE; Pennings JL; Gottschalk WH; Kleinjans JC; van Delft JH; van Steeg H; Luijten M
    Toxicol Sci; 2011 Sep; 123(1):123-32. PubMed ID: 21715664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atm-null mice exhibit enhanced radiation-induced birth defects and a hybrid form of embryonic programmed cell death indicating a teratological suppressor function for ATM.
    Laposa RR; Henderson JT; Xu E; Wells PG
    FASEB J; 2004 May; 18(7):896-8. PubMed ID: 15033931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity to cadmium-chloride-induced forelimb ectrodactyly is independent of the p53 gene-dosage in the C57BL/6J mouse.
    Elsaid AF; Koriem KM; Collins MD
    Birth Defects Res A Clin Mol Teratol; 2010 Apr; 88(4):223-7. PubMed ID: 20213698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
    Wang Y; Zhang Z; Kastens E; Lubet RA; You M
    Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental abnormalities induced by X-irradiation in p53 deficient mice.
    Baatout S; Jacquet P; Michaux A; Buset J; Vankerkom J; Derradji H; Yan J; von Suchodoletz H; de Saint-Georges L; Desaintes C; Mergeay M
    In Vivo; 2002; 16(3):215-21. PubMed ID: 12182118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Participation of cytochrome P-448 in 3,4-benzopyrene metabolism during induction by different xenobiotics in inbred mouse strains].
    Mishina DV; Mishin VM; Liakhovich VV
    Dokl Akad Nauk SSSR; 1985; 283(2):487-9. PubMed ID: 4042833
    [No Abstract]   [Full Text] [Related]  

  • 13. Embryotoxicity of benzo(a)pyrene and some of its synthetic derivatives in Swiss mice.
    Barbieri O; Ognio E; Rossi O; Astigiano S; Rossi L
    Cancer Res; 1986 Jan; 46(1):94-8. PubMed ID: 3753553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A common carcinogen benzo[a]pyrene causes p53 overexpression in mouse cervix via DNA damage.
    Gao M; Li Y; Sun Y; Long J; Kong Y; Yang S; Wang Y
    Mutat Res; 2011 Sep; 724(1-2):69-75. PubMed ID: 21745588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subset of p53-deficient embryos exhibit exencephaly.
    Sah VP; Attardi LD; Mulligan GJ; Williams BO; Bronson RT; Jacks T
    Nat Genet; 1995 Jun; 10(2):175-80. PubMed ID: 7663512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis.
    Iskander K; Gaikwad A; Paquet M; Long DJ; Brayton C; Barrios R; Jaiswal AK
    Cancer Res; 2005 Mar; 65(6):2054-8. PubMed ID: 15781611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetically mediated induction of drug-metabolizing enzymes associated with congenital defects in the mouse.
    Lambert GH; Nebert DW
    Teratology; 1977 Oct; 16(2):147-53. PubMed ID: 412268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility of wild and knockout p53 FVB/N line mice to benz(a)pyrene-induced subcutaneous sarcoma].
    Anikin IV; Kozlov AP; Popov AV; Zabezhinskiĭ MA; Tyndyk ML; Anisimov VN
    Vopr Onkol; 2002; 48(6):700-2. PubMed ID: 12530267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure.
    Oda H; Zhang S; Tsurutani N; Shimizu S; Nakatsuru Y; Aizawa S; Ishikawa T
    Cancer Res; 1997 Feb; 57(4):646-50. PubMed ID: 9044841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Teratogen-induced eye defects mediated by p53-dependent apoptosis.
    Wubah JA; Ibrahim MM; Gao X; Nguyen D; Pisano MM; Knudsen TB
    Curr Biol; 1996 Jan; 6(1):60-9. PubMed ID: 8805222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.